title: Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why?
authors.affiliation: Institute of Endocrinology, Pisa, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Marcocci
authors.forename: L
authors.initials: L
authors.lastname: Bartalena
authors.forename: G
authors.initials: G
authors.lastname: Bruno-Bossio
authors.forename: G
authors.initials: G
authors.lastname: Vanni
authors.forename: F
authors.initials: F
authors.lastname: Cartei
authors.forename: F
authors.initials: F
authors.lastname: Bogazzi
authors.forename: A
authors.initials: A
authors.lastname: Pinchera
mesh_terms: D001327:Autoimmune Diseases / Q000532:radiotherapy*; D006801:Humans; D009915:Orbit / Q000528:radiation effects; D009916:Orbital Diseases / Q000532:radiotherapy*; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D012307:Risk Factors; D013959:Thyroid Diseases / Q000532:radiotherapy*